- 現金殖利率: 3.39%、總殖利率: 3.39%、5年平均現金配發率: 65.12%
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
| EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 (10) | 1.06 | -7.02 | 1.00 | 0.0 | 0.00 | 0 | 94.34 | 7.55 | 0.00 | 0 | 94.34 | 7.55 |
| 2022 (9) | 1.14 | -42.71 | 1.00 | 11.11 | 0.00 | 0 | 87.72 | 93.96 | 0.00 | 0 | 87.72 | -3.02 |
| 2021 (8) | 1.99 | 729.17 | 0.90 | 542.86 | 0.90 | 0 | 45.23 | -22.47 | 45.23 | 0 | 90.45 | 55.06 |
| 2020 (7) | 0.24 | -4.0 | 0.14 | 40.0 | 0.00 | 0 | 58.33 | 45.83 | 0.00 | 0 | 58.33 | 45.83 |
| 2019 (6) | 0.25 | 0 | 0.10 | 0 | 0.00 | 0 | 40.00 | 0 | 0.00 | 0 | 40.00 | 0 |
| 2018 (5) | -1.09 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2017 (4) | -1.62 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2016 (3) | 1.54 | -32.16 | 0.80 | -55.56 | 0.00 | 0 | 51.95 | -34.49 | 0.00 | 0 | 51.95 | -34.49 |
| EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 24Q3 (20) | 0.29 | -44.23 | -40.82 | 0.00 | -100.0 | -100.0 | 1.50 | 23.97 | 172.73 |
| 24Q2 (19) | 0.52 | -24.64 | 73.33 | 0.33 | 175.0 | 57.14 | 1.21 | 75.36 | 1916.67 |
| 24Q1 (18) | 0.69 | 35.29 | 387.5 | 0.12 | -85.54 | 128.57 | 0.69 | -34.91 | 387.5 |
| 23Q4 (17) | 0.51 | 4.08 | 215.91 | 0.83 | 1975.0 | 253.7 | 1.06 | 92.73 | -7.02 |
| 23Q3 (16) | 0.49 | 63.33 | 512.5 | 0.04 | -80.95 | 112.12 | 0.55 | 816.67 | -65.19 |
| 23Q2 (15) | 0.30 | 225.0 | -45.45 | 0.21 | 150.0 | -50.0 | 0.06 | 125.0 | -96.0 |
| 23Q1 (14) | -0.24 | 45.45 | -123.08 | -0.42 | 22.22 | -227.27 | -0.24 | -121.05 | -123.08 |
| 22Q4 (13) | -0.44 | -650.0 | -165.67 | -0.54 | -63.64 | -200.0 | 1.14 | -27.85 | -43.0 |
| 22Q3 (12) | 0.08 | -85.45 | -91.49 | -0.33 | -178.57 | -137.5 | 1.58 | 5.33 | 18.8 |
| 22Q2 (11) | 0.55 | -47.12 | 77.42 | 0.42 | 27.27 | 10.53 | 1.50 | 44.23 | 284.62 |
| 22Q1 (10) | 1.04 | 55.22 | 1200.0 | 0.33 | -38.89 | 312.5 | 1.04 | -48.0 | 1200.0 |
| 21Q4 (9) | 0.67 | -28.72 | 570.0 | 0.54 | -38.64 | 1450.0 | 2.00 | 50.38 | 733.33 |
| 21Q3 (8) | 0.94 | 203.23 | 77.36 | 0.88 | 131.58 | 633.33 | 1.33 | 241.03 | 850.0 |
| 21Q2 (7) | 0.31 | 287.5 | 203.33 | 0.38 | 375.0 | 416.67 | 0.39 | 387.5 | 200.0 |
| 21Q1 (6) | 0.08 | -20.0 | 180.0 | 0.08 | 300.0 | 300.0 | 0.08 | -66.67 | 180.0 |
| 20Q4 (5) | 0.10 | -81.13 | 0 | -0.04 | -133.33 | -150.0 | 0.24 | 71.43 | -4.0 |
| 20Q3 (4) | 0.53 | 276.67 | 0.0 | 0.12 | 200.0 | 0.0 | 0.14 | 135.9 | 0.0 |
| 20Q2 (3) | -0.30 | -200.0 | 0.0 | -0.12 | -200.0 | 0.0 | -0.39 | -290.0 | 0.0 |
| 20Q1 (2) | -0.10 | 0 | 0.0 | -0.04 | -150.0 | 0.0 | -0.10 | -140.0 | 0.0 |
| 19Q4 (1) | 0.00 | 0.0 | 0.0 | 0.08 | 0.0 | 0.0 | 0.25 | 0.0 | 0.0 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/10 | 0.38 | 13.67 | 7.32 | 3.26 | 14.15 | 0.97 | N/A | - | ||
| 2024/9 | 0.33 | 29.73 | -5.85 | 2.88 | 15.12 | 0.94 | 1.51 | - | ||
| 2024/8 | 0.26 | -26.13 | -14.96 | 2.54 | 18.59 | 0.87 | 1.64 | - | ||
| 2024/7 | 0.35 | 33.44 | 20.74 | 2.29 | 24.12 | 0.99 | 1.44 | - | ||
| 2024/6 | 0.26 | -30.34 | -4.78 | 1.94 | 24.75 | 0.96 | 1.25 | - | ||
| 2024/5 | 0.38 | 15.67 | 32.49 | 1.67 | 31.11 | 1.03 | 1.17 | - | ||
| 2024/4 | 0.32 | -0.79 | 15.25 | 1.3 | 30.71 | 0.96 | 1.25 | - | ||
| 2024/3 | 0.33 | 7.0 | 7.48 | 0.97 | 36.83 | 0.97 | 1.0 | - | ||
| 2024/2 | 0.31 | -10.39 | 25.45 | 0.65 | 58.75 | 1.04 | 0.94 | 近年歐洲市場開發耕耘有成帶來效益，加上日本、美國客戶區間拉貨影響，致使本月營收增加。 | ||
| 2024/1 | 0.34 | -12.21 | 108.27 | 0.34 | 108.27 | 1.15 | 0.85 | 歐洲市場開發耕耘有成帶來效益，加上中國客戶因應春節停工年前拉貨影響，歐洲、中國客戶出貨較去年同期成長，致使本月營收增加。 | ||
| 2023/12 | 0.39 | -6.41 | 90.56 | 3.66 | 2.75 | 1.16 | 0.91 | 歐洲市場開發耕耘有成，並進入出貨旺季，另受到美國、中國客戶出貨較去年 基期相較回穩，致使本月營收顯著增加 | ||
| 2023/11 | 0.42 | 17.25 | 105.82 | 3.27 | -2.58 | 1.12 | 0.94 | 歐洲市場開發耕耘有成，並進入出貨旺季，另受到美國、中國客戶出貨較去年 基期相較回穩，致使本月營收顯著增加 | ||
| 2023/10 | 0.35 | -0.28 | 75.23 | 2.85 | -9.51 | 1.01 | 1.05 | 歐洲市場開發耕耘有成，並進入出貨旺季，另受到美國、中國客戶出貨較去年基期相較回穩，致使本月營收顯著增加 | ||
| 2023/9 | 0.36 | 17.17 | 37.71 | 2.5 | -15.32 | 0.95 | 1.41 | - | ||
| 2023/8 | 0.3 | 4.89 | 18.73 | 2.14 | -20.4 | 0.87 | 1.55 | - | ||
| 2023/7 | 0.29 | 5.22 | -5.22 | 1.84 | -24.5 | 0.85 | 1.58 | - | ||
| 2023/6 | 0.27 | -3.07 | -15.82 | 1.55 | -27.25 | 0.84 | 1.68 | - | ||
| 2023/5 | 0.28 | 0.62 | 2.0 | 1.28 | -29.32 | 0.87 | 1.62 | - | ||
| 2023/4 | 0.28 | -7.47 | -25.44 | 0.99 | -35.01 | 0.83 | 1.7 | - | ||
| 2023/3 | 0.3 | 24.89 | -31.83 | 0.71 | -38.15 | 0.71 | 2.09 | - | ||
| 2023/2 | 0.24 | 48.75 | -26.93 | 0.41 | -42.16 | 0.61 | 2.44 | - | ||
| 2023/1 | 0.16 | -19.68 | -55.84 | 0.16 | -55.84 | 0.57 | 2.62 | 受市場景氣及一月份工作天數影響生產及相關運輸調配，致使出貨及訂單趨緩，營運收入較去年同期下滑 | ||
| 2022/12 | 0.2 | 1.08 | -50.67 | 3.56 | -22.12 | 0.61 | 2.8 | 受市場景氣變化、全球通膨影響，致使出貨及訂單趨緩，營運收入較去年同期下滑 | ||
| 2022/11 | 0.2 | -0.17 | -50.39 | 3.36 | -19.28 | 0.66 | 2.57 | |||
| 2022/10 | 0.2 | -21.63 | -49.82 | 3.15 | -15.9 | 0.72 | 2.38 | - | ||
| 2022/9 | 0.26 | 1.02 | -48.77 | 2.95 | -11.82 | 0.82 | 2.2 | - | ||
| 2022/8 | 0.26 | -16.27 | -45.79 | 2.69 | -5.27 | 0.89 | 2.03 | - | ||
| 2022/7 | 0.31 | -6.54 | -34.33 | 2.44 | 2.76 | 0.91 | 1.98 | - | ||
| 2022/6 | 0.33 | 17.45 | -11.78 | 2.13 | 11.79 | 0.98 | 2.0 | - | ||
| 2022/5 | 0.28 | -26.44 | -14.99 | 1.81 | 17.47 | 1.1 | 1.78 | - | ||
| 2022/4 | 0.38 | -15.4 | 9.37 | 1.53 | 26.23 | 1.16 | 1.69 | - | ||
| 2022/3 | 0.45 | 33.86 | 31.27 | 1.15 | 32.95 | 1.15 | 1.62 | - | ||
| 2022/2 | 0.33 | -10.1 | 21.96 | 0.7 | 34.03 | 1.12 | 1.66 | - | ||
| 2022/1 | 0.37 | -10.26 | 47.12 | 0.37 | 47.12 | 1.19 | 1.56 | - | ||
| 2021/12 | 0.41 | 1.66 | 30.59 | 4.57 | 29.17 | 1.22 | 1.32 | - | ||
| 2021/11 | 0.41 | 0.97 | 24.25 | 4.16 | 29.03 | 1.31 | 1.23 | - | ||
| 2021/10 | 0.4 | -20.0 | 12.86 | 3.75 | 29.58 | 1.38 | 1.17 | - | ||
| 2021/9 | 0.5 | 6.9 | 46.1 | 3.35 | 31.93 | 1.44 | 0.94 | - | ||
| 2021/8 | 0.47 | 1.42 | 40.08 | 2.84 | 29.7 | 1.31 | 1.04 | - | ||
| 2021/7 | 0.46 | 25.55 | 52.68 | 2.37 | 27.82 | 1.16 | 1.17 | 主要受惠於歐美地區逐步解封，帶動整體新車銷售市場。 | ||
| 2021/6 | 0.37 | 13.18 | 33.23 | 1.91 | 22.94 | 1.04 | 0.97 | - | ||
| 2021/5 | 0.33 | -5.36 | 40.56 | 1.54 | 20.7 | 1.01 | 1.0 | - | ||
| 2021/4 | 0.35 | 1.53 | 37.82 | 1.21 | 16.27 | 0.96 | 1.05 | - | ||
| 2021/3 | 0.34 | 24.37 | 3.57 | 0.87 | 9.44 | 0.87 | 1.02 | - | ||
| 2021/2 | 0.27 | 8.43 | 26.59 | 0.53 | 13.61 | 0.84 | 1.04 | - | ||
| 2021/1 | 0.25 | -20.34 | 2.24 | 0.25 | 2.24 | 0.9 | 0.98 | - | ||
| 2020/12 | 0.32 | -3.27 | -6.07 | 3.54 | 2.04 | 1.0 | 0.81 | - | ||
| 2020/11 | 0.33 | -8.27 | 7.94 | 3.22 | 2.91 | 1.03 | 0.79 | - | ||
| 2020/10 | 0.36 | 3.55 | 18.64 | 2.89 | 2.37 | 1.04 | 0.78 | - | ||
| 2020/9 | 0.34 | 2.5 | 10.87 | 2.54 | 0.43 | 0.99 | 0.88 | - | ||
| 2020/8 | 0.34 | 10.54 | 9.46 | 2.19 | -1.02 | 0.92 | 0.95 | - | ||
| 2020/7 | 0.3 | 9.56 | 0.58 | 1.86 | -2.71 | 0.81 | 1.07 | - | ||
| 2020/6 | 0.28 | 19.42 | -13.44 | 1.55 | -3.33 | 0.76 | 1.2 | - | ||
| 2020/5 | 0.23 | -7.2 | -26.7 | 1.27 | -0.81 | 0.81 | 1.12 | - | ||
| 2020/4 | 0.25 | -23.69 | -19.11 | 1.04 | 7.67 | 0.8 | 1.14 | - | ||
| 2020/3 | 0.33 | 52.0 | 36.0 | 0.79 | 20.3 | 0.79 | 1.26 | - | ||
| 2020/2 | 0.22 | -12.41 | 8.37 | 0.46 | 11.19 | 0.8 | 1.25 | - | ||
| 2020/1 | 0.25 | -26.83 | 13.79 | 0.25 | 13.79 | 0.89 | 1.13 | - | ||
| 2019/12 | 0.34 | 11.16 | 46.72 | 3.47 | -7.36 | 0.0 | N/A | - | ||
| 2019/11 | 0.3 | 0.81 | 35.21 | 3.13 | -10.9 | 0.0 | N/A | - |
